Analysis of Plasma Surgery Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
A new research study by Fact.MR places the global plasma surgery market at a value of US$ 73.3 million in 2024 and projects it to ascend to US$ 121.4 million by the end of 2034. The market has been forecasted to expand at 5.2% CAGR from 2024 to 2034.
Use of plasma infusion helps create exact and targeted tissue incisions during surgical procedures. The market for plasma surgeries is growing at a steady pace because this approach offers benefits over conventional procedures, such as shorter recovery times and less scarring.
The market is steadily moving in the upward direction because companies involved are taking initiatives to spread awareness and benefits of treatments regarding blood disorders that are becoming prevalent. Plasma surgery is a medical procedure that uses ionized gas, or plasma to make precise incisions and remove tissue without damaging the surrounding area and help in various blood disorders. It has been widely used in various medical areas such as dermatology and ophthalmology.
People suffering from blood disorders are shifting toward plasma surgery from traditional surgical methods as it is minimally invasive and less painful and entails reduced bleeding and shorter recovery time. These factors are working favorably to attract more patients with blood disorders to opt for plasma surgery. The market is projected to continue its steady expansion owing to the introduction of platelet-rich plasma. This technique significantly enhances wound healing and tissue regeneration.
Key Market Growth Drivers
| Report Attribute | Detail |
|---|---|
| Plasma Surgery Market Size (2024E) | US$ 73.3 Million |
| Forecasted Market Value (2034F) | US$ 121.4 Million |
| Global Market Growth Rate (2024 to 2034) | 5.2% CAGR |
| North America Market Share (2024E) | 43.8% |
| East Asia Market Value (2024E) | US$ 9 Million |
| Plasma Ablation Systems Segment Value (2034F) | US$ 77.3 Million |
| Dissection Segment Value (2034F) | US$ 60.8 Million |
| Hospitals Segment Value (2034F) | US$ 69.1 Million |
| Key Companies Profiled | Johnson & Johnson; Exactech, Inc.; Terumo Medical Corporation; CSL Ltd; DePuy Synthes, Inc.; Biotest Aktiengesellschaft; Zimmer Biomet Holdings, Inc.; Arthex, Inc.; Stryker Corporation; Nuo Therapeutics; AdiStem Ltd. |
“Shift toward Minimally Invasive Surgical Technologies and Demand for Shorter Recovery Times”
Growing propensity toward minimally invasive surgical technologies is driving market growth. However, plasma surgeries provide some benefits over normal surgeries such as small incisions with less trauma to surrounding tissues, minimal scarring, and shorter recovery times than traditional surgery. These surgeries also necessitate shorter hospital stays, allowing patients to resume activity faster. As a result, healthcare providers are adopting plasma surgery systems to respond to the increasing need for minimally invasive procedures, resulting in better patient outcomes and a high level of surgical care.
“Adoption of Advanced Technology to Improve Precision and Patient Outcomes”
Ongoing technological advancements are transforming surgical procedures through innovation that improves precision, efficiency, and above all patient safety in surgical outcomes. Low-temperature systems, also referred to as cold plasma systems, are designed in such a way that the susceptible tissue remains unharmed while the plasma plays its role of sterilization and hastening the wound healing process. Control mechanisms are designed in a way that they are used to regulate the amount of energy to be used on selective tissues for effective treatment with minimum to no damage to non-target tissues.
“High Initial Cost of Equipment and Maintenance Expenditure”
High equipment cost is a factor that is hampering the adoption of plasma surgery systems in healthcare facilities. Since these systems are primarily based on advanced technology and come with unique devices, the initial purchase and subsequent upkeep expenditures are substantial.
Healthcare facilities that have limited funding or are prone to resource shortages face financial problems in buying and maintaining plasma surgical equipment. Because of this, some medical professionals favor less expensive options. High prices of plasma surgery equipment lead to an increase in the cost of surgery, which may not be affordable for all patients.
North America is estimated to lead with 43.8% of the global plasma surgery market share in 2024. The East Asia market is projected to expand at 5.1% CAGR from 2024 to 2034, and this region is becoming a lucrative market for surgery providers due to the increasing prevalence of orthopedic and neurological diseases, and the rising application of platelet-rich plasma products.
“Market Benefitting from Robust Healthcare Sector and Use of Advanced Surgical Equipment”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 28 Million |
| Growth Rate (2024 to 2034) | 5.8% CAGR |
| Projected Value (2034F) | US$ 50 Million |
Well-developed healthcare sector in terms of the use of advanced equipment and excellent healthcare service availability in the United States are key reasons for the increasing adoption of plasma surgery. Also, increasing funding from the government and investors for improving surgery systems for more effectiveness is contributing to increasing sales. The United States attracts patients from all over the world due to high-end facilities and the trust of people.
“Rising Demand for Skin Treatments to Address Skin Rejuvenation and Wrinkle Reduction”
| Attribute | China |
|---|---|
| Market Value (2024E) | US$ 4 Million |
| Growth Rate (2024 to 2034) | 5.4% CAGR |
| Projected Value (2034F) | US$ 8 Million |
Demand for skin treatments is on the rise in China. The efficacy of plasma surgery in treating a range of skin diseases is boosting its adoption in the country. Many individuals seek plasma surgery for skin rejuvenation, wrinkle reduction, scar removal, and skin tightening. The demand for these cosmetic procedures is driven by the desire for a more youthful look and enhanced skin texture in China.
Based on application, the market is segmented into ablation, resection, and dissection. The dissection segment is poised to account for 49.7% of the global market share in 2024 and is forecasted to capture more than half of the market by the end of 2034.
“Minimal Invasiveness of Plasma Ablation Ensuring Pain Reduction and Shorter Recovery Time”
| Attribute | Plasma Ablation Systems |
|---|---|
| Segment Value (2024E) | US$ 46.2 Million |
| Growth Rate (2024 to 2034) | 5.3% CAGR |
| Projected Value (2034F) | US$ 77.3 Million |
Plasma ablation systems are in increased demand because they provide several advantages over conventional surgical methods. Plasma ablation is a minimally invasive technique that removes tissue accurately while sparing nearby healthy tissues. This results in less pain, less scarring, and a faster recovery time for patients. In addition, several diseases such as cancer, skin blemishes, and gynecological issues are effectively treated with plasma ablation. Because of this, despite the high equipment costs, healthcare facilities are still adopting plasma surgery due to its wide coverage.
“Greater Capacity of Hospitals to Invest in Expensive Equipment”
| Attribute | Hospitals |
|---|---|
| Segment Value (2024E) | US$ 40.5 Million |
| Growth Rate (2024 to 2034) | 5.5% CAGR |
| Projected Value (2034F) | US$ 69.1 Million |
Based on end user, the hospitals segment is set to account for 63% revenue share in 2024. Plasma surgery systems are not budget-friendly for all. Compared to ambulatory surgical centers and specialty clinics, hospitals generally have a higher capacity to invest in advanced equipment. Another reason is patients prefer hospitals for treatment and surgeries. However, specialty clinics are also estimated to create excellent opportunities in the coming years due to the increasing number of cosmetic procedures for treating skin-related problems.
Key players in the plasma surgery market are focusing on applying several strategies to boost sales and increase awareness of this surgery such as introducing competitive pricing systems with developments in safety features, investing in advanced equipment, collaborating and partnering with other companies, and adopting digital media.
Fact.MR provides detailed information about the price points of prominent players in the plasma surgery market positioned across the world, sales growth, production capacity, and speculative technological expansion, in this new market report.
How big is the plasma surgery market?
The global market for plasma surgery is estimated at US$ 73.3 million in 2024.
What is the demand projection for plasma surgery for 2034?
Worldwide revenue from plasma surgery is projected to reach US$ 121.4 million by 2034.
At what rate is the global market forecasted to grow?
The plasma surgery market is forecasted to increase at 5.2% CAGR between 2024 and 2034.
How fast is the market projected to expand in Japan?
The market in Japan is projected to expand at 5% CAGR through 2034.
Who are the leading companies involved in plasma surgery?
Leading market players are Johnson & Johnson, Exactech, Inc., Terumo Medical Corporation, CSL Ltd., and DePuy Synthes, Inc.
Which application holds a leading share of the market?
Based on application, the dissection segment is projected to account for 50.1% market share by 2034.
What is the demand projection for plasma ablation systems?
Revenue from plasma ablation systems is projected to reach US$ 77.3 million by 2034.
Which region is forecasted to hold a high percentage of the global market share?
The North American region is forecasted to account for 45.8% of the global market share by 2034.
Plasma Surgery Market